For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Acelrx Pharmaceuticals, Inc.

USPTO Granted Patents = 26

% Expired Patents = 3.8

CIPO Patents = 5

EPO Patents = 11

Trademarks = 3

Forward Citations = 1,176

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Andrew I Poutiatine (24 out of 43 patents)

Pamela Palmer (22 out of 34 patents)

Thomas A Schreck (21 out of 29 patents)

4. Stelios Tzannis (19 out of 27 patents)

5. Larry Hamel (15 out of 16 patents)

6. Charles Rampersaud (13 out of 17 patents)

7. Bruce P Edwards (11 out of 42 patents)

8. Edmond Chiu (6 out of 8 patents)

9. Lawrence Hamel (5 out of 5 patents)

10. William Kolosi (5 out of 18 patents)

11. Sascha Retailleau (5 out of 8 patents)

12. Benjamin K Yaffe (3 out of 31 patents)

13. Bradley Blackwood (3 out of 14 patents)

14. Casidy Domingo (1 out of 4 patents)

15. Shamim Pushpala (1 out of 2 patents)

Core Competencies:

Oral Transmucosal Dosage Forms

Sufentanil

Drug Dispensing Devices

Bioadhesive Formulations

Storage Devices

Administration Methods

Flexible Push Rod

Oxygen Scavengers

Small Volume Dosage Forms

Pain Treatment

26 patents: Sort by Forward Citations

1. 11058856 - Systems, devices and methods for dispensing oral transmucosal dosage forms (2021-07-13),

2. 10896751 - Storage and dispensing devices for administration of oral transmucosal dosage forms (2021-01-19),

3. 10709881 - Apparatus for administering small volume oral transmucosal dosage forms (2020-07-14),

4. 10507180 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2019-12-17),

5. 10342762 - Small-volume oral transmucosal dosage forms (2019-07-09),

6. 10245228 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2019-04-02),

7. 9744129 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2017-08-29),

8. 9642996 - Methods and apparatus for administering small volume oral transmucosal dosage forms (2017-05-09),

9. 9320710 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2016-04-26),

10. 9289583 - Methods for administering small volume oral transmucosal dosage forms using a dispensing device (2016-03-22),

11. 8945592 - Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same (2015-02-03),

12. 8905964 - Drug storage and dispensing devices and systems comprising the same (2014-12-09),

13. 8865743 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2014-10-21),

14. 8865211 - Bioadhesive drug formulations for oral transmucosal delivery (2014-10-21),

15. 8778394 - Small-volume oral transmucosal dosage forms (2014-07-15),

Company Overview

AcelRx Pharmaceuticals, Inc. is a biopharmaceutical company based in Redwood City, California, focused on the development and commercialization of innovative therapies for the treatment of acute pain. The company specializes in novel drug delivery systems and formulations, aiming to improve patient outcomes and enhance the management of pain in various clinical settings. AcelRx's research emphasizes the use of sublingual and other non-invasive delivery methods, positioning it at the forefront of pain management solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

26 Patents

#77 in Redwood City, CA

#3,041 in California

#12,859 in US

#24,806 in the World

Redwood City, CA, United States of America

Acelrx Pharmaceuticals, Inc.

Forward Citations = 1,176

17 inventors:

Andrew I Poutiatine (24 out of 43 patents)

Pamela Palmer (22 out of 34 patents)

Thomas A Schreck (21 out of 29 patents)

4. Stelios Tzannis (19 out of 27 patents)

5. Larry Hamel (15 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Acelrx Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/acelrx-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…